Skip to main content

Advertisement

SpringerLink
Log in

Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Between June 2003 and November 2004, we collected mobilized peripheral blood units from 29 patients with non-Hodgkin’s lymphoma and multiple myeloma for autologous peripheral blood stem cell transplantation. They received granulocyte colony-stimulating factor (G-CSF) (16 μg/kg/day) for a total of 5 days. Immediately before and 3 h after the fourth and fifth dose of G-CSF, we performed flow cytometry analysis to quantify: T cells (CD3+CD4+, CD3+CD8+), B cells (CD19+), NK cells (CD3-CD16+CD56+), NKT cells (CD3+CD16+CD56+), type 1 dendritic cells (DC1) (lin-HLA-DR+CD11c+), type 2 dendritic cells (DC2) (lin-HLA-DR+CD123+), regulatory T cells (Tregs) (CD4+CD25+), and activated T cells (CD3+HLA-DR+). All cell subsets were mobilized after G-CSF treatment with the exception of B, NK, and NKT lymphocytes. The median number of Treg cells before and after G-CSF was statistically different (29±14.9×106/l vs 70.1±46.1×106/l, P<0.02). DCs were mobilized significantly with a 5.9-fold increase in DC2 (15.1±30.3×106/l vs 89.8±81.0×106/l, P<0.02) and a 2.6-fold increase for DC1 (41±42.5×106/l vs 109.5±58.0×106/l, P<0.04). Patients received a mean of 3.1±1.2×107/kg NK cells, 1.3±0.9×107/kg NKT cells, 0.41±0.29×107/kg DC1, 0.2±0.22×107/kg DC2, and 1.8±1.9×107/kg Tregs. In conclusion, intermediate doses of G-CSF induce mobilization of different lymphocyte subsets, with the exception of B, NK, and NKT cells. The mobilization of certain suppressive populations (DC2 and Treg) could be in theory deleterious, at least in patients with cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bensinger WI, Weaver CH, Appelbaum FR (1995) Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655–1658

    CAS  PubMed  Google Scholar 

  2. Bolwell B, Sobecks R, Pohlman B, Andresen S, Theil K, Serafino S, Rybicki L, Kalaycio M (2003) Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone. Bone Marrow Transplant 31:95–98

    Article  CAS  PubMed  Google Scholar 

  3. Chin-Yee I, Keeney M, Anderson L, Nayar R, Sutherland DR (1997) Current status of CD34+ cell analysis by flow cytometry. The ISHAGE Guidelines. Clin Immunol 17:21–29

    Article  Google Scholar 

  4. Damiani D, Fanin R, Silvestri F (1997) Randomized trial of autologous filgrastim-primed bone marrow transplantation versus filgrastim-mobilized peripheral blood stem cell transplantation in lymphoma patients. Blood 90:36–42

    CAS  PubMed  Google Scholar 

  5. Dhodapkar MV, Geller MD, Chang DH, Shimizu K, Fujii SI, Dhodapkar KM, Krasovsky J (2003) A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J Exp Med 197:1667–1676

    Article  CAS  PubMed  Google Scholar 

  6. Dreger P, Haferlach T, Eckstein V (1994) G-CSF mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol 87:609–613

    Article  CAS  PubMed  Google Scholar 

  7. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330–336

    Article  CAS  PubMed  Google Scholar 

  8. Gasparetto C, Gasparetto M, Morse M, Rooney B, Vredenburgh JJ, Long GD, Rizzieri DA, Loftis J, Chao NJ, Smith C (2002) Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-ligand and G-CSF or GM-CSF. Cytokine 18:8–19

    Article  CAS  PubMed  Google Scholar 

  9. Gavin MA (2002) Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo. Nat Immunol 3:33–41

    Article  CAS  PubMed  Google Scholar 

  10. Lanza F, Healy J, Sutherland DR (2001) Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents 15:1–13

    CAS  PubMed  Google Scholar 

  11. Levings MK, Sangregorio R, Galbiati F, Squadrone S, De Waal Malefyt R, Roncarolo MG (2001) IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 166:5530–5539

    CAS  PubMed  Google Scholar 

  12. Liso A, Stockerl-Goldstein K, Aufferman-Gretziner S, Benike C, Reichardt V, Van Beckhoven A, Rajapaksa R, Engelman E, Blume K, Levy R (2000) Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 6:621–627

    Article  CAS  PubMed  Google Scholar 

  13. Lonial S, Hicks M, Rosenthal H, Langston A, Redei I, Torre C, Duenzl M, Feinstein B, Cherry J, Waller E (2004) A randomized trial comparing the combination of granulocyte–macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products. Biol Blood Marrow Transplant 10:848–857

    Article  CAS  PubMed  Google Scholar 

  14. McHugh RS (2002) CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role of the glucocorticoid-induced TNF receptor. Immunity 16:311–323

    Article  CAS  PubMed  Google Scholar 

  15. Miller JS, Prosper F, McCullar V (1997) Natural killer (NK) cells are functionally abnormal and NK cells progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood 90:3098–3105

    CAS  PubMed  Google Scholar 

  16. Morse M, Zhou L, Tedder T, Lyerly H, Smith C (1997) Generation of dendritic cells in vitro from peripheral blood mononuclear cells with GM-CSF, IL-4 and TNF-α. Ann Surg 226:6–16

    Article  CAS  PubMed  Google Scholar 

  17. Morse MA, Nair S, Fernandez-Casal M, Deng Y, St Peter M, Williams R, Hobeika A, Mosca P, Clay T, Ian Cumming R, Fisher E, Clavien P, Proia AD, Niedzwiecki D, Caron D, Lyerly H (2000) Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer. J Clin Oncol 18(23):3883–3893

    CAS  PubMed  Google Scholar 

  18. Peron JM, Esche C, Subbotin VM, Maliszewski C, Lotze MT, Shurin MR (1998) Flt3-ligand administration inhibits liver metastases: role of NK cells. J Immunol 161:6164–6170

    CAS  PubMed  Google Scholar 

  19. Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, Mariotti A, Scambia G, d’Onofrio G, Leone G (2002) Role for granulocyte colony-stimulating factor in the generation of human T regulatory type I cells. Blood 100(7):2562–2571

    Article  CAS  PubMed  Google Scholar 

  20. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155(3):1151–1164

    CAS  PubMed  Google Scholar 

  21. Sheridan WP, Begley CG, Juttner CA (1992) Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640–644

    Article  CAS  PubMed  Google Scholar 

  22. Shier LR, Schultz KR, Imren S, Regan J, Issekutz A, Sadek I, Gilman A, Luo Z, Panzarella T, Eaves CJ, Couban S (2004) Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors. Biol Blood Marrow Transplant 10:624–634

    Article  CAS  PubMed  Google Scholar 

  23. Shimizu J, Yamazaki S, Sakaguchi S (1999) Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol 162:5211–5218

    Google Scholar 

  24. Shpall EJ, Wheeler CA, Turner SA (1999) A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients. Blood 93:2491–2501

    CAS  PubMed  Google Scholar 

  25. Siena S, Bregni M, Brando B, Ravagnani F, Bonadona G, Gianni AM (1989) Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte–macrophage colony-stimulating factor. Blood 74:1905–1914

    CAS  PubMed  Google Scholar 

  26. Simmet SJ, Stewart LA, Sweetenham J, Morgan G, Johnson PWM (2000) Autologous stem cell transplantation for malignancy: a systematic review of the literature. Clin Lab Haematol 22(2):61–72

    Article  Google Scholar 

  27. Sosman JA, Stiff P, Moss SM, Sorokin P, Martone B, Bayer R, Van Besien K, Devine S, Stock W, Peace D, Chen Y, Long C, Gustin D, Viana M, Hoffman R (2001) Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-stem-cell infusion. J Clin Oncol 19:634–644

    CAS  PubMed  Google Scholar 

  28. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-yee I (1996) The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother 5:213–226

    CAS  PubMed  Google Scholar 

  29. Theilgaard-Mönch K, Raaschou-Jensen K, Palm H, Schjodt K, Heilmann C, Vindelov L, Jaconsen N, Dickmeiss E (2001) Flow cytometry assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant 28:1073–1082

    Article  PubMed  Google Scholar 

  30. Timmerman JM, Levy R (1999) Dendritic cell vaccination for cancer immunotherapy. Annu Rev Med 50:507–529

    Article  CAS  PubMed  Google Scholar 

  31. To LB, Shepperd KM, Haylock DN (1990) Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 18:442–449

    CAS  PubMed  Google Scholar 

  32. Van Maurik A, Herber M, Wood KJ, Jones ND (2002) Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 169(10):5401–5404

    PubMed  Google Scholar 

  33. Weaver CH, Birch R, Greco FA (1998) Mobilisation and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim. Br J Haematol 100:338–347

    Article  CAS  PubMed  Google Scholar 

  34. Woo EY, Chi CS, Goletz TJ, Schlienger K, Yeh H, Coukos G (2001) Regulatory CD4+CD25+ T cells in tumors from patients with early-stage non-small lung cancer and late stage ovarian cancer. Cancer Res 61:4766–4772

    CAS  PubMed  Google Scholar 

Download references

Acknowledgement

This work was partially supported by grant No. 2004-123 from the FOFOI (Fondo de Fomento a la Investigación, Dirección de Prestaciones Médicas, Coordinación de Investigación en Salud, Instituto Mexicano del Seguro Social, México). The experiments performed in the present paper complied with the current laws of Mexico and were approved by the Ethical Committee in La Raza Medical Center.

Author information

Authors and Affiliations

  1. Hematology Department, Stem Cell Transplant Program, Unidad Médica de Alta Especialidad “Antonio Fraga Mouret” National Medical Center “La Raza”, Instituto Mexicano del Seguro Social, Mexico City, Mexico

    J. Vela-Ojeda, M. A. García-Ruiz Esparza, L. Montiel-Cervantes, F. Tripp-Villanueva, M. Ayala-Sánchez & L. D. García-León

  2. Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico

    J. Vela-Ojeda, E. Reyes-Maldonado, L. Jiménez-Zamudio, E. García-Latorre, M. Moreno-Lafont, I. Estrada-García & L. Montiel-Cervantes

  3. Oncological Research Unit, Oncology Hospital, National Medical Center, Instituto Mexicano del Seguro Social, Mexico City, Mexico

    H. Mayani

  4. Bone Marrow Transplant Program, Hospital San José-Tec de Monterrey, Monterrey, Nuevo León, Mexico

    J. R. Borbolla-Escoboza

  5. Medical School, Instituto Tecnológico y de Estudios Superiores de Monterrey, Monterrey, Nuevo León, Mexico

    J. R. Borbolla-Escoboza

  6. Hematology Department, Stem Cell Transplant Program, Hospital de Especialidades Centro Médico La Raza, IMSS, Apartado Postal 14-878, CP 07001, México Distrito Federal, Mexico

    J. Vela-Ojeda

Authors
  1. J. Vela-Ojeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. A. García-Ruiz Esparza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Reyes-Maldonado
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Jiménez-Zamudio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. García-Latorre
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Moreno-Lafont
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. Estrada-García
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. Mayani
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. L. Montiel-Cervantes
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. F. Tripp-Villanueva
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. M. Ayala-Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. L. D. García-León
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. J. R. Borbolla-Escoboza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Vela-Ojeda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vela-Ojeda, J., García-Ruiz Esparza, M.A., Reyes-Maldonado, E. et al. Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma. Ann Hematol 85, 308–314 (2006). https://doi.org/10.1007/s00277-006-0090-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-006-0090-8

Keywords

Search

Navigation